Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Harbinger HealthHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$470.04MSeries B-12/20/2025$289.97M$781.26M$6.60Undisclosed Investors
MapLight TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$511MSeries D9/30/2025$200M$883.21M$0.95Catalyst4, Forbion, Sanofi, Novo Holdings
OriginHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Osteal TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Quanta TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$168.34MSeries D6/24/2026$76.19M$253.34M$1.44Avidity Partners, Sofinnova Investments, Vida Ventures, Surveyor Capital, Longitude Capital, BVF Partners, AbbVie Ventures, GC&H Investments, WS Investment Company
Sionna TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$331.32MSeries C3/6/2024$181.86M$523.7M$9.76Enavate Sciences, Viking Global Investors, Perceptive Advisors, RA Capital, TPG, Atlas Venture, Cystic Fibrosis Foundation, T. Rowe Price, Qatar Investment Authority, OrbiMed
TwinStrand BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
ValoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$406.25MSeries B3/9/2021$310M$919.92M$5.88PSP Investments, Flagship Pioneering, Invus Public Equities, HBM Healthcare Investments, Atinum Investment, Mirae Asset Capital, Koch Disruptive Technologies
AcepodiaHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
AlltrnaHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
BlueWillow BiologicsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$37.19MSeries C9/19/2022$5.9M$34.12M$0.09Undisclosed Investors
CullgenHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$116MSeries C5/8/2023$35M$264.09M$2.63AstraZeneca-CICCVentureCapitalPartnership, SincereCapital, VoyagersCapital, WuxiCapitalGroup, GHIGroup
EnsomaHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$250.75MSeries B-17/2/2025$45.2M$281.79M$1.09Undisclosed Investors
EvommuneHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$268.46MSeries C10/31/2024$115.5M$346.35M$1.59RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management
Flare TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$290.35MSeries C6/30/2026$85M$188.49M$0.37Third Rock Ventures, Nextech Invest, Pfizer, Boxer Capital, GordonMD Global Investments, Invus, Casdin Capital, Eli Lilly and Company, Novartis, Agent Capital, Eventide Asset Management
MBX BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$216.64MSeries C8/5/2024$63.5M$316.71M$1.03Deep Track Capital, Driehaus Capital Management, T. Rowe Price Associates, Frazier Life Sciences, OrbiMed, Wellington Management
Obsidian TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$329.03MSeries C4/3/2024$160.5M$480.83M$1.90Wellington Management, Foresite Capital, Janus Henderson Investors, Novo Holdings, Paradigm BioCapital, RTW Investments, T. Rowe Price Associates, Woodline Partners, Atlas Venture, Blue Owl Capital, Bristol Myers Squibb, Deep Track Capital, Logos Capital, RA Capital Management, TCG Crossover Management, Samsara, Surveyor Capital
PhlowHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$96.11MSeries C-17/22/2025$34.88M$417.6M$18.09Align Private Capital
SynthegoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$415.07MSeries E2/17/2022$144.17M$1.3B$10.78Perceptive Advisors, SoftBank, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund, Chimera Abu Dhabi, Wellington Management, RA Capital Management, Moore Strategic Ventures
Zenas BioPharmaHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Alleviant MedicalHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$182.73MSeries 21/14/2025$91.4M$258.67M$1.28Gilde Healthcare, Omega Funds, S3 Ventures, RiverVest Venture Partners, Vensana Capital, Longview Ventures, Gilmartin Capital, TMC Corporation
Alloplex BiotherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$20.67MSeries A1/27/2023$20.67M$279.9M$68.60Undisclosed Investors
Alto NeuroscienceHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$253.17MSeries C11/21/2023$50.31M$235.65M$4.71InVivium Capital, Franklin Templeton, Point72, Eli Lilly and Company, Alexandria Venture Investments, Alpha Wave Ventures, Lightswitch Capital, Alkeon Capital, WhatIf Ventures, Windham Venture Partners
BioAgeHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.42BSeries D2/13/2024$170M$440.23M$3.42Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.